PI3K/Akt/mTOR Signaling
Research Areas
Products Related to PI3K/Akt/mTOR Signaling(719)
- GC19283PF-04979064CAS: 1220699-06-8Purity: >99.50%
PF-04979064 is a potent and selective PI3K/mTOR dual kinase inhibitor with Kis of 0.13 nM and 1.42 nM for PI3Kα and mTOR, respectively.
- GC19286PF-06409577CAS: 1467057-23-3Purity: >99.00%
PF-06409577 is a potent and selective allosteric activator of AMPK α1β1γ1 isoform with an EC50 of 7 nM.
- GC19355UmbralisibCAS: 1532533-67-7Purity: >98.50%
TGR-1202 is a PI3Kδ inhibitor, with IC50 and EC50 of 22.2 nM and 24.3 nM, respectively.
- GC19540α-Linolenic AcidCAS: 463-40-1Purity: >99.50%
An essential fatty acid found in leafy green vegetables
- GC19843NimbolideCAS: 25990-37-8Purity: >98.00%
Nimbolide is a triterpene derived from the leaves and flowers of Azadirachta indica L. Nimbolide inhibits NF- κ B induces tumor cell apoptosis. Nimbolide inhibited CDK4 / Cdk6 kinase activity. Nimbolide inhibits NF- κ B. Wnt, PI3K Akt, MAPK and JAK-STAT signaling pathways.
- GC250184-Vinylcyclohexene dioxideCAS: 106-87-6Purity: >96.00%
4-Vinylcyclohexene dioxide (VCD), a metabolite of 4-vinylcyclohexene (VCH), is synthesized in industries as an intermediate diluent for epoxy resins and other epoxides.
- GC25626MELK-8a DihydrochlorideCAS: 1922153-17-0 (free base)Purity: >98%
MELK-8a Dihydrochloride is a novel inhibitor of maternal embryonic leucine zipper kinase (MELK) with an IC50 of 2 nM.
- GC25638Miransertib (ARQ 092) HClCAS: 1313883-00-9Purity: >98%
Miransertib (ARQ 092) HCl is an orally bioavailable, selective, and potent allosteric Akt inhibitor with IC 50 values of 2.7nM, 14nM, and 8.1nM for Akt1, Akt2, and Akt3, respectively.
- GC25913Selective PI3Kδ Inhibitor 1 (compound 7n)CAS: 2088525-31-7Purity: >98%
Selective PI3Kδ Inhibitor 1 (compound 7n) is an inhibitor of PI3Kδ with an IC50 of 0.9 nM and >1000-fold selectivity against other class I PI3K isoforms [PI3K α/γ/β=3670/1460/21300 nM].
- GC26044VPS34 inhibitor 1 (Compound 19)CAS: 1383716-46-8Purity: >98%
VPS34 inhibitor 1 (Compound 19, PIK-III analogue) is a potent and selective inhibitor of VPS34 with an IC50 of 15 nM.
- GC26049WAY-119064CAS: 1198098-03-1Purity: >98%
WAY-119064 is a potent glycogen synthase kinase-3β (GSK-3β) inhibitor with an IC50 value of 80.5 nM.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC19202 | IPI549 | 1693758-51-8 | >98.50% | |
IPI549 (IPI549) is a potent and selective PI3Kγ inhibitor with an IC50 of 16 nM. IPI549 shows >100-fold selectivity over other lipid and protein kinases. | ||||
| GC19227 | LTURM34 | 1879887-96-3 | >99.00% | |
LTURM34 is a specific DNA-PK inhibitor with an IC50 of 0.034 uM. | ||||
| GC19256 | MTX-211 | 1952236-05-3 | >98.00% | |
MTX-211 is a dual inhibitor of EGFR and PI3K, used for the treatment of cancer and other diseases. | ||||
| GC19269 | O-304 | 1261289-04-6 | >99.50% | |
O-304 is a small molecule AMPK activator. | ||||
| GC19283 | PF-04979064 | 1220699-06-8 | >99.50% | |
PF-04979064 is a potent and selective PI3K/mTOR dual kinase inhibitor with Kis of 0.13 nM and 1.42 nM for PI3Kα and mTOR, respectively. | ||||
| GC19286 | PF-06409577 | 1467057-23-3 | >99.00% | |
PF-06409577 is a potent and selective allosteric activator of AMPK α1β1γ1 isoform with an EC50 of 7 nM. | ||||
| GC19300 | PQR309 | 1225037-39-7 | >98.50% | |
PQR309 is a potent, brain-penetrant, orally bioavailable, pan-class I PI3K/mTOR inhibitor with IC50s of 33nM, 451nM, 661nM, 708nM and 89nM for PI3Kα, PI3Kδ, PI3Kβ, PI3Kγ and mTOR, respectively. | ||||
| GC19328 | SF2523 | 1174428-47-7 | >98% | |
SF2523 is a highly selective and potent inhibitor of PI3K with IC50s of 34 nM, 158 nM, 9 nM, 241 nM and 280 nM for PI3Kα, PI3Kγ, DNA-PK, BRD4 and mTOR, respectively. | ||||
| GC19355 | Umbralisib | 1532533-67-7 | >98.50% | |
TGR-1202 is a PI3Kδ inhibitor, with IC50 and EC50 of 22.2 nM and 24.3 nM, respectively. | ||||
| GC19390 | YU238259 | 1943733-16-1 | >99.50% | |
YU238259 is an inhibitor of homology-dependent DNA repair (HDR), used for cancer research. | ||||
| GC19411 | IITZ-01 | 1807988-47-1 | >99.00% | |
IITZ-01 is a potent lysosomotropic autophagy inhibitor with single-agent antitumor activity, with an IC50 of 2.62 μM for PI3Kγ. | ||||
| GC19471 | Leniolisib | 1354690-24-6 | >99.00% | |
A potent and selective PI3Kδ inhibitor | ||||
| GC19484 | BAY1125976 | 1402608-02-9 | >99.50% | |
A selective allosteric Akt1/Akt2 inhibitor | ||||
| GC19540 | α-Linolenic Acid | 463-40-1 | >99.50% | |
An essential fatty acid found in leafy green vegetables | ||||
| GC19843 | Nimbolide | 25990-37-8 | >98.00% | |
Nimbolide is a triterpene derived from the leaves and flowers of Azadirachta indica L. Nimbolide inhibits NF- κ B induces tumor cell apoptosis. Nimbolide inhibited CDK4 / Cdk6 kinase activity. Nimbolide inhibits NF- κ B. Wnt, PI3K Akt, MAPK and JAK-STAT signaling pathways. | ||||
| GC19921 | Phenylarsine Oxide | 637-03-6 | >98.00% | |
| GC25018 | 4-Vinylcyclohexene dioxide | 106-87-6 | >96.00% | |
4-Vinylcyclohexene dioxide (VCD), a metabolite of 4-vinylcyclohexene (VCH), is synthesized in industries as an intermediate diluent for epoxy resins and other epoxides. | ||||
| GC25626 | MELK-8a Dihydrochloride | 1922153-17-0 (free base) | >98% | |
MELK-8a Dihydrochloride is a novel inhibitor of maternal embryonic leucine zipper kinase (MELK) with an IC50 of 2 nM. | ||||
| GC25638 | Miransertib (ARQ 092) HCl | 1313883-00-9 | >98% | |
Miransertib (ARQ 092) HCl is an orally bioavailable, selective, and potent allosteric Akt inhibitor with IC 50 values of 2.7nM, 14nM, and 8.1nM for Akt1, Akt2, and Akt3, respectively. | ||||
| GC25648 | MOTS-c | 1627580-64-6 | >98.00% | |
MOTS-c is a mitochondrial-derived polypeptide with metabolic regulatory functions. | ||||
| GC25913 | Selective PI3Kδ Inhibitor 1 (compound 7n) | 2088525-31-7 | >98% | |
Selective PI3Kδ Inhibitor 1 (compound 7n) is an inhibitor of PI3Kδ with an IC50 of 0.9 nM and >1000-fold selectivity against other class I PI3K isoforms [PI3K α/γ/β=3670/1460/21300 nM]. | ||||
| GC26044 | VPS34 inhibitor 1 (Compound 19) | 1383716-46-8 | >98% | |
VPS34 inhibitor 1 (Compound 19, PIK-III analogue) is a potent and selective inhibitor of VPS34 with an IC50 of 15 nM. | ||||
| GC26049 | WAY-119064 | 1198098-03-1 | >98% | |
WAY-119064 is a potent glycogen synthase kinase-3β (GSK-3β) inhibitor with an IC50 value of 80.5 nM. | ||||
| GC30015 | TMPA | 1258275-73-8 | >98.50% | |
TMPA, a Nur77 antagonist, prevents the binding of Nur77 and LKB1 as well as stimulates LKB1 transport to the cytosol and phosphorylation. | ||||
